Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Return on Assets for 14 consecutive years, with 0.34% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets fell 75.0% year-over-year to 0.34%; the TTM value through Mar 2026 reached 0.34%, down 75.0%, while the annual FY2025 figure was 0.28%, 80.0% down from the prior year.
  • Return on Assets hit 0.34% in Q1 2026 for Agios Pharmaceuticals, down from 0.31% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.52% in Q3 2024 and bottomed at 0.45% in Q2 2024.
  • Average Return on Assets over 5 years is 0.05%, with a median of 0.11% recorded in 2023.
  • Year-over-year, Return on Assets crashed -115bps in 2022 and then skyrocketed 88bps in 2025.
  • Agios Pharmaceuticals' Return on Assets stood at 0.0% in 2022, then plummeted by -11332bps to 0.37% in 2023, then skyrocketed by 206bps to 0.39% in 2024, then crashed by -180bps to 0.31% in 2025, then fell by -10bps to 0.34% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.34%, 0.31%, and 0.28% for Q1 2026, Q4 2025, and Q3 2025 respectively.